Novartis operated through a wholly owned subsidiary in India on July 1, 2026.
2 reports, 2 independent
Updated Sep 10
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Novartis operated through a wholly owned subsidiary in India on July 1, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Novartis is shifting its R&D focus to India, moving operations outside of Switzerland.Sub-event
Novartis utilized a wholly owned subsidiary for operations in India.1 source
Keep exploring
The entities involved
-
Novartis
Swiss-American multinational pharmaceutical corporation
Related events
- Novartis is headquartered in Basel, Switzerland.
- Novartis AG is subject to US federal securities laws.
- Novartis is offering potential support to the national health fund in Ghana, which provides equipment and support to the Komfo Anokye Teaching Hospital.
- Novartis utilizes SAP for core inventory management.
- Novartis sought Swissmedic regulatory approval for a drug, which was co-funded by Sida and introduced first in Ghana.